Reviewed Mar 2026 | Sources: PubMed

BPC-157 vs LL-37: Head-to-Head Comparison

BPC-157 is primarily a healing peptide that promotes tissue repair, while LL-37 is a human cathelicidin antimicrobial peptide that serves as a first-line immune defense. LL-37 has direct antimicrobial activity against bacteria, fungi, and viruses, while BPC-157 focuses on structural tissue recovery.

Side-by-Side Comparison

DimensionBPC-157LL-37
Evidence LevelExtensive animal studiesHuman endogenous peptide, well-characterized; clinical studies ongoing
FDA StatusNot approvedNot approved as therapeutic
MechanismAngiogenesis, growth factor modulation, NO pathwayMembrane disruption of pathogens, immune cell recruitment, wound healing
Primary UseTissue repair: gut, tendon, ligamentAntimicrobial defense, biofilm disruption, wound healing
Antimicrobial ActivityNot a primary mechanismBroad-spectrum: antibacterial, antifungal, antiviral
Side EffectsMinimal in animal studiesPotential cytotoxicity at high concentrations, injection site reactions
Evidence Level
BPC-157
Extensive animal studies
LL-37
Human endogenous peptide, well-characterized; clinical studies ongoing
FDA Status
BPC-157
Not approved
LL-37
Not approved as therapeutic
Mechanism
BPC-157
Angiogenesis, growth factor modulation, NO pathway
LL-37
Membrane disruption of pathogens, immune cell recruitment, wound healing
Primary Use
BPC-157
Tissue repair: gut, tendon, ligament
LL-37
Antimicrobial defense, biofilm disruption, wound healing
Antimicrobial Activity
BPC-157
Not a primary mechanism
LL-37
Broad-spectrum: antibacterial, antifungal, antiviral
Side Effects
BPC-157
Minimal in animal studies
LL-37
Potential cytotoxicity at high concentrations, injection site reactions

Peptide Overviews

BPC-157

CPreclinical

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. Preclinical research suggests it may accelerate wound healing and protect organs from damage.

Healing & RecoveryNot Approved
View full BPC-157 profile →

LL-37

CPreclinical

LL-37 is the only cathelicidin antimicrobial peptide found in humans. It plays a crucial role in innate immune defense, wound healing, and inflammation modulation.

Immune SupportNot Approved
View full LL-37 profile →

BPC-157 vs LL-37: FAQ

Stay Informed on Peptide Research

Get weekly comparison updates, new study alerts, and regulatory changes.

No spam. Unsubscribe anytime.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.